PLSH (Panacea Life Sciences Holdings) Beginning Cash Position: $1.45 Mil (As of Sep. 2025)


What is Panacea Life Sciences Holdings Beginning Cash Position?

Panacea Life Sciences Holdings PLSH +39.60% Beginning Cash Position is $1.45 Mil as of Sep. 2025. The stock has 6 warning signs investors should review.

Panacea Life Sciences Holdings's Beginning Cash Position for the quarter that ended in Sep. 2025 was $1.45 Mil.

Panacea Life Sciences Holdings's quarterly Beginning Cash Position declined from Mar. 2025 ($1.37 Mil) to Jun. 2025 ($-0.84 Mil) but then increased from Jun. 2025 ($-0.84 Mil) to Sep. 2025 ($1.45 Mil).

Panacea Life Sciences Holdings's annual Beginning Cash Position declined from Dec. 2021 ($0.08 Mil) to Dec. 2022 ($0.02 Mil) and declined from Dec. 2022 ($0.02 Mil) to Dec. 2023 ($0.01 Mil).

Panacea Life Sciences Holdings Beginning Cash Position Related Terms

Panacea Life Sciences Holdings Beginning Cash Position Historical Data

* Premium members only.

The historical data trend for Panacea Life Sciences Holdings's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Panacea Life Sciences Holdings Beginning Cash Position Chart

Panacea Life Sciences Holdings Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Beginning Cash Position
8.52 0.08 0.02 0.01

Panacea Life Sciences Holdings Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Mar25 Jun25 Sep25
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.11 0.19 1.37 -0.84 1.45

Panacea Life Sciences Holdings Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

What does a Beginning Cash Position of $1.45 Mil mean?
Panacea Life Sciences Holdings (PLSH) has a Beginning Cash Position of $1.45 Mil as of Sep. 2025. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Panacea Life Sciences Holdings and its competitors.
Is Panacea Life Sciences Holdings' Beginning Cash Position too high?
Panacea Life Sciences Holdings' current Beginning Cash Position is $1.45 Mil.
How does Panacea Life Sciences Holdings' Beginning Cash Position compare to SKYI and IMCC?
Panacea Life Sciences Holdings' Beginning Cash Position of $1.45 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beginning Cash Position for a Drug Manufacturers company?
A good Beginning Cash Position depends on the Drug Manufacturers industry context. However, Beginning Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beginning Cash Position mean?
A high Beginning Cash Position can signal that a stock is expensive relative to its fundamentals. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Panacea Life Sciences Holdings and its competitors. Panacea Life Sciences Holdings's current Beginning Cash Position is $1.45 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Panacea Life Sciences Holdings stock overvalued right now?
Panacea Life Sciences Holdings (PLSH) has a current Beginning Cash Position of $1.45 Mil. The current Beginning Cash Position is $1.45 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beginning Cash Position calculated?
Beginning Cash Position is calculated from a company's financial statements. For Panacea Life Sciences Holdings (PLSH), the current Beginning Cash Position is $1.45 Mil as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Panacea Life Sciences Holdings Business Description

Address 5910 South University Boulevard, C18-193, Greenwood Village, CO, USA, 80121
Panacea Life Sciences Holdings Inc is a holding company organized as a plant-based natural health ingredient and product company, specializing in the development, manufacturing, research, and distribution of products and rapidly growing natural health and wellness market segment for both humans and animals. The company also offers the purest natural remedies within its branded product lines for every aspect of life: PANA Health, PANA Beauty, PANA Sport, PANA Pet, PANA Pure and PANA Life.